文献速递脑血管病

基底动脉闭塞的静脉溶栓:结局及与血管内取栓的比较

IV Thrombolysis in Basilar Artery Occlusion: Outcomes and Comparison With Endovascular Thrombectomy.
PubMed 文献 · Neurology · 2024-03-26

该单中心回顾性队列研究纳入1995-2022年发病48小时内接受再通治疗的376例基底动脉闭塞患者,其中245例(65.2%)仅接受静脉溶栓。2010-2022年队列中,仅静脉溶栓组(n=122)3个月良好功能结局58.2%,血管内取栓±静脉溶栓组(n=121)为43.0%(aOR 2.82,95%CI 1.31-6.05)。作者认为静脉溶栓不应被忽视,可作为急性基底动脉闭塞的一线再通治疗。

要点

  • 仅静脉溶栓组3个月良好功能结局46.5%,死亡率35.9%,症状性颅内出血11.1%。
  • 2010-2022年队列中,仅静脉溶栓组良好功能结局58.2%,取栓±溶栓组43.0%(aOR 2.82)。
  • 作者认为静脉溶栓不应被忽视,可作为急性基底动脉闭塞的一线再通治疗。

核心结论

  • 仅静脉溶栓的结局与近期血管内再通试验相当,在本队列头对头比较中更常与良好结局相关。
  • 作者认为静脉溶栓不应被忽视,即使时间窗较长也可作为急性基底动脉闭塞的一线再通治疗。

研究设计与样本

  • 观察性单中心回顾性队列研究,纳入1995-2022年发病48小时内接受静脉溶栓和/或血管内取栓的连续基底动脉闭塞患者。
  • 第一部分描述1995-2022年仅静脉溶栓队列的结局及相关因素;第二部分用双稳健逆概率加权回归调整模型比较2010-2022年静脉溶栓与取栓±静脉溶栓的结局。
  • 全队列376例,其中245例(65.2%)仅接受静脉溶栓。

主要发现

  • 仅静脉溶栓队列多数患者临床表现中重度(中位NIHSS 18),后循环无广泛早期缺血改变,半数发病至治疗时间超过6小时。
  • 仅静脉溶栓患者46.5%达到3个月良好功能结局,死亡率35.9%,症状性颅内出血发生率为11.1%。
  • 多变量分析中,较年轻、症状较轻和基线缺血改变较少预测良好功能结局。
  • 2010-2022年队列中,仅静脉溶栓组(n=122)良好功能结局58.2%,取栓±静脉溶栓组(n=121)为43.0%,aOR 2.82(95%CI 1.31-6.05)。

关键数值与推荐

  • 主要结局为3个月良好功能结局(改良Rankin量表0-3分),由卒中医生电话收集。
  • 2010-2022年队列中,仅静脉溶栓组(n=122)良好功能结局58.2% vs 取栓±静脉溶栓组(n=121)43.0%(aOR 2.82,95%CI 1.31-6.05)。
  • 仅静脉溶栓队列3个月良好功能结局46.5%,死亡率35.9%,症状性颅内出血11.1%。
  • 证据等级:本研究提供IV级证据,表明tPA对基底动脉血栓形成与取栓同样有效。

临床怎么用

  • 作者认为静脉溶栓不应被忽视,即使时间窗较长也可作为急性基底动脉闭塞的一线再通治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Recanalization is considered a prerequisite for favorable outcome in basilar artery occlusion (BAO). Intravenous thrombolysis (IVT) has been successfully used for eligible patients with BAO well beyond the 4.5-hour time window but has been largely underrepresented in the best medical management arms in recent randomized controlled trials of recanalization therapy in BAO. We aimed to analyze the outcomes of patients with BAO treated with IVT only and to compare IVT with endovascular thrombectomy (EVT). METHODS: This observational single-center, retrospective cohort study included consecutive patients with BAO treated with IVT and/or EVT up to 48 hours of symptom onset during 1995-2022. The primary outcome was favorable functional outcome (modified Rankin Scale 0-3) at 3 months collected by a stroke physician by phone. In the first part, we described the outcomes and factors associated with functional outcome in the IVT-only cohort during 1995-2022. In the second part, we used doubly robust inverse probability-weighted regression adjustment models to compare functional outcome of patients treated with IVT vs EVT+/-IVT during 2010-2022. RESULTS: In the whole cohort of 376 patients with acute BAO treated with recanalization therapy, 245 (65.2%) received only IVT. In the IVT-only cohort, most patients had moderate-to-severe clinical presentation (median NIH Stroke Scale 18) but no extensive early ischemic changes in the posterior circulation on admission. Half of them had onset-to-treatment time over 6 hours. 46.5% of the IVT-treated patients achieved 3-month favorable functional outcome, whereas mortality was 35.9%. sICH occurred in 11.1%. In a multivariable analysis, younger age, milder symptom severity, and less baseline ischemic changes predicted favorable functional outcome. In the 2010-2022 cohort, when compared with patients treated with EVT+/-IVT (n = 121), the IVT-only cohort (n = 122) had higher odds for favorable functional outcome (IVT 58.2% vs EVT 43.0% (aOR 2.82 [95% CI 1.31-6.05]). DISCUSSION: IVT alone produced outcomes comparable with those in recent trials of endovascular BAO recanalization. Furthermore, in head-to-head comparison in our cohort, the IVT-only approach was more often associated with favorable outcome than EVT+/-IVT. Thus, it should not be overlooked as the first-line recanalization therapy in acute BAO, even in longer time windows. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that tPA is as effective as thrombectomy for basilar artery thrombosis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Räty S, Virtanen P, Ritvonen J, et al. IV Thrombolysis in Basilar Artery Occlusion: Outcomes and Comparison With Endovascular Thrombectomy. Neurology. 2024. PMID: 38531004. doi:10.1212/WNL.0000000000209249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。